Last reviewed · How we verify
NMS-03597812
At a glance
| Generic name | NMS-03597812 |
|---|---|
| Sponsor | Nerviano Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia (PHASE1)
- Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |